Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+0.13%+4.41%+47.35%+163.20% 1,06800Cr
+0.97%+6.88%+58.02%+53.12% 64TCr
-0.94%+1.39%+35.02%+72.60% 45TCr
+0.31%+8.03%+38.37%+33.85% 35TCr
+0.31%+2.47%+37.82%+42.54% 30TCr
-0.88%+2.23%+18.36%+15.49% 27TCr
+0.60%+1.34%-27.21%-37.85% 22TCr
+0.06%+3.32%+22.73%+59.40% 20TCr
+0.94%-2.02%+12.32%+70.59% 16TCr
Average +0.62%+2.76%+26.98%+52.55% 40.7TCr
Weighted average by Cap. +0.86%+2.85%+36.56%+77.84%
Logo Shire
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-